Lista de obras -

A novel diagnostic criterion for lymph node metastasis in cervical cancer using multi-detector computed tomography

artículo científico publicado en 2013

ASGO 2nd International Workshop on Gynecologic Oncology

artículo científico publicado en 2013

Acquisition of a side population fraction augments malignant phenotype in ovarian cancer

scientific article published on 02 October 2019

Activated local immunity by CC chemokine ligand 19-transduced embryonic endothelial progenitor cells suppresses metastasis of murine ovarian cancer

artículo científico publicado en 2010

Adenoid cystic carcinoma of skene glands: a rare origin in the female genital tract and the characteristic clinical course

artículo científico publicado en 2012

Adult granulosa cell tumors of the ovary: a retrospective study of 30 cases with respect to the expression of steroid synthesis enzymes.

artículo científico publicado en 2017

Advanced extragonadal yolk sac tumor serially followed up with (18)F-fluorodexyglucose-positoron emission tomography and computerized tomography and serum alpha-fetoprotein

artículo científico publicado en 2012

Anti-PD-L1/PD-1 immune therapies in ovarian cancer: basic mechanism and future clinical application.

artículo científico publicado en 2016

Anti-VEGF therapy resistance in ovarian cancer is caused by GM-CSF-induced myeloid-derived suppressor cell recruitment

artículo científico publicado en 2020

Antitumor Effect of Nivolumab on Subsequent Chemotherapy for Platinum-Resistant Ovarian Cancer

artículo científico publicado en 2018

Assessment of the early predictive power of quantitative magnetic resonance imaging parameters during neoadjuvant chemotherapy for uterine cervical cancer.

artículo científico publicado en 2014

Chemotherapy Induces Programmed Cell Death-Ligand 1 Overexpression via the Nuclear Factor-κB to Foster an Immunosuppressive Tumor Microenvironment in Ovarian Cancer

artículo científico publicado en 2015

Classification using hierarchical clustering of tumor-infiltrating immune cells identifies poor prognostic ovarian cancers with high levels of COX expression

artículo científico publicado en 2008

Clear cell carcinoma arising from a uterus-like mass

artículo científico publicado en 2014

Clinical approaches to treating papillary squamous cell carcinoma of the uterine cervix.

artículo científico publicado en 2014

Clinical efficacy of neoadjuvant chemotherapy with irinotecan (CPT-11) and nedaplatin followed by radical hysterectomy for locally advanced cervical cancer

artículo científico publicado en 2016

Clinical significance of the NKG2D ligands, MICA/B and ULBP2 in ovarian cancer: high expression of ULBP2 is an indicator of poor prognosis

artículo científico publicado en 2008

Clinicopathological prognostic factors and the role of cytoreduction in surgical stage IVb endometrial cancer: A retrospective multi-institutional analysis of 248 patients in Japan ⬇️

artículo científico publicado el 19 de agosto de 2012

Combination of Aprepitant, Azasetron, and Dexamethasone as Antiemetic Prophylaxis in Women with Gynecologic Cancers Receiving Paclitaxel/Carboplatin Therapy.

artículo científico publicado en 2017

Comparison of treatment invasiveness between upfront debulking surgery versus interval debulking surgery following neoadjuvant chemotherapy for stage III/IV ovarian, tubal, and peritoneal cancers in a phase III randomised trial: Japan Clinical Oncol

artículo científico publicado en 2016

Comprehensive assessment of the expression of the SWI/SNF complex defines two distinct prognostic subtypes of ovarian clear cell carcinoma.

artículo científico publicado en 2016

Cyclical change of hMSH2 protein expression in normal endometrium during the menstrual cycle and its overexpression in endometrial hyperplasia and sporadic endometrial carcinoma

artículo científico publicado en 2002

Distinct preoperative clinical features predict four histopathological subtypes of high-grade serous carcinoma of the ovary, fallopian tube, and peritoneum.

artículo científico publicado en 2017

Distinguishing primary from secondary mucinous ovarian tumors: an algorithm using the novel marker DPEP1.

artículo científico publicado en 2010

Dual Faces of IFNγ in Cancer Progression: A Role of PD-L1 Induction in the Determination of Pro- and Antitumor Immunity

artículo científico publicado en 2016

Endometrial cancer implanted within a cesarean section scar

artículo científico publicado en 2011

Eph-ephrin A system regulates human choriocarcinoma-derived JEG-3 cell invasion.

artículo científico publicado en 2013

Epigenetic and genetic dispositions of ovarian carcinomas

artículo científico publicado en 2014

Epigenetic determinants of ovarian clear cell carcinoma biology.

artículo científico publicado en 2014

Epigenetic suppression of the TGF-beta pathway revealed by transcriptome profiling in ovarian cancer.

artículo científico publicado en 2010

Establishment of a Novel Histopathological Classification of High-Grade Serous Ovarian Carcinoma Correlated with Prognostically Distinct Gene Expression Subtypes

artículo científico publicado en 2016

Evidence-based guidelines for treatment of cervical cancer in Japan: Japan Society of Gynecologic Oncology (JSGO) 2007 edition.

artículo científico publicado en 2010

Evidence-based guidelines for treatment of uterine body neoplasm in Japan: Japan Society of Gynecologic Oncology (JSGO) 2009 edition.

artículo científico publicado en 2010

Exome Sequencing Landscape Analysis in Ovarian Clear Cell Carcinoma Shed Light on Key Chromosomal Regions and Mutation Gene Networks.

artículo científico publicado en 2017

Expression of Vascular Endothelial Growth Factor in Ovarian Cancer Inhibits Tumor Immunity through the Accumulation of Myeloid-Derived Suppressor Cells.

artículo científico publicado en 2016

Expression of p53 and p21(WAF-1), apoptosis, and proliferation of smooth muscle cells in normal myometrium during the menstrual cycle: implication of DNA damage and repair for leiomyoma development

artículo científico publicado en 2012

Functional genomics identifies five distinct molecular subtypes with clinical relevance and pathways for growth control in epithelial ovarian cancer

artículo científico publicado en 2013

GPR54 is a target for suppression of metastasis in endometrial cancer

artículo científico publicado en 2011

Genomic profile predicts the efficacy of neoadjuvant chemotherapy for cervical cancer patients

artículo científico publicado en 2015

Groin lymph node detection and sentinel lymph node biopsy in vulvar cancer

artículo científico publicado en 2016

Hepatocyte nuclear factor-1β (HNF-1β) promotes glucose uptake and glycolytic activity in ovarian clear cell carcinoma

artículo científico publicado en 2013

Highly conserved binding region of ACE2 as a receptor for SARS-CoV-2 between humans and mammals

scientific article published on 12 September 2020

Humoral hypercalcemia caused by uterine corpus carcinosarcoma consisting of squamous cell carcinoma in its epithelial component

scientific article published on 05 September 2013

Immune checkpoint (PD-1 and CTIA-4) signal inhibitors for gynecologic oncology; up to date

scientific article published on 01 February 2017

Immune checkpoint inhibition in ovarian cancer

artículo científico publicado en 2016

Immunological aspect of metastasis of ovarian cancer

artículo científico publicado el 1 de junio de 2012

Impaired Wnt5a signaling in extravillous trophoblasts: Relevance to poor placentation in early gestation and subsequent preeclampsia

scientific article published on 05 July 2018

Invasion of uterine cervical squamous cell carcinoma cells is facilitated by locoregional interaction with cancer-associated fibroblasts via activating transforming growth factor-beta

scientific article published on 28 November 2014

LH/hCG action and development of ovarian cancer--a short review on biological and clinical/epidemiological aspects

artículo científico publicado en 2007

Loss of Fhit protein expression in high-grade and advanced stage endometrial carcinomas.

artículo científico publicado en 2003

MR imaging-based evaluation of morphological changes in the uterus and ovaries of patients following neoadjuvant chemotherapy for cervical cancer.

artículo científico publicado en 2014

Magnetic resonance imaging findings and prognosis of gastric-type mucinous adenocarcinoma (minimal deviation adenocarcinoma or adenoma malignum) of the uterine corpus: Two case reports.

artículo científico publicado en 2016

Menstrual cyclic change of metastin/GPR54 in endometrium

scientific article published on 08 June 2014

Metabolic alterations caused by HNF1β expression in ovarian clear cell carcinoma contribute to cell survival

artículo científico publicado en 2015

Metabolomic Profiles of Placenta in Preeclampsia

scientific article published on 01 March 2019

Minimal deviation mucinous adenocarcinoma ('adenoma malignum') of the uterine corpus

artículo científico publicado en 2010

Nationwide survey of severe postpartum hemorrhage in Japan: an exploratory study using the national database of health insurance claims

article

Oct4 Expression in Immature Teratoma of the Ovary

article

Outcomes of fertility-sparing surgery for stage I epithelial ovarian cancer: a proposal for patient selection

artículo científico publicado en 2010

Ovarian cancer in endometriosis: molecular biology, pathology, and clinical management

artículo científico publicado en 2009

Ovarian clear cell carcinoma as a stress-responsive cancer: influence of the microenvironment on the carcinogenesis and cancer phenotype.

artículo científico

Ovarian clear cell carcinoma meets metabolism; HNF-1β confers survival benefits through the Warburg effect and ROS reduction

artículo científico publicado en 2015

PD-1/PD-L1 blockade in cancer treatment: perspectives and issues

artículo científico publicado en 2016

PD-L1 on tumor cells is induced in ascites and promotes peritoneal dissemination of ovarian cancer through CTL dysfunction

artículo científico publicado en 2013

Phase II trial of oral etoposide plus intravenous irinotecan in patients with platinum-resistant and taxane-pretreated ovarian cancer (JCOG0503).

artículo científico publicado en 2014

Phase III trial of upfront debulking surgery versus neoadjuvant chemotherapy for stage III/IV ovarian, tubal and peritoneal cancers: Japan Clinical Oncology Group Study JCOG0602

artículo científico publicado en 2008

Placental sonic hedgehog pathway regulates foetal growth via insulin-like growth factor axis in preeclampsia

artículo científico publicado en 2019

Prediction of taxane and platinum sensitivity in ovarian cancer based on gene expression profiles

artículo científico publicado en 2016

Primary squamous cell carcinoma of fallopian tube accompanied by gastric metaplasia of female genital tract: case report and review

artículo científico publicado en 2011

Prospects and Problems of Cancer Genome Analysis for Establishing Cancer Precision Medicine

scientific article published on 09 September 2019

Recurrence of a carcinoid tumor of the ovary 13 years after the primary surgery: A case report

artículo científico publicado en 2013

STAT1 drives tumor progression in serous papillary endometrial cancer.

artículo científico publicado en 2014

Safety and Antitumor Activity of Anti-PD-1 Antibody, Nivolumab, in Patients With Platinum-Resistant Ovarian Cancer

artículo científico publicado en 2015

Snail promotes ovarian cancer progression by recruiting myeloid-derived suppressor cells via CXCR2 ligand upregulation.

artículo científico publicado en 2018

Solitary fibrous tumor arising slowly in the vulva over 10 years: case report and review.

artículo científico

Sorafenib efficacy in ovarian clear cell carcinoma revealed by transcriptome profiling.

artículo científico publicado en 2010

Stress affects uterine receptivity through an ovarian-independent pathway.

artículo científico publicado en 2008

Subendometrial enhancement and peritumoral enhancement for assessing endometrial cancer on dynamic contrast enhanced MR imaging

artículo científico publicado en 2015

Suppression of ABHD2, identified through a functional genomics screen, causes anoikis resistance, chemoresistance and poor prognosis in ovarian cancer

artículo científico publicado en 2016

Suppression of metastatic murine ovarian cancer cells by transduced embryonic progenitor cells

artículo científico publicado en 2010

Survival outcome of stage I ovarian clear cell carcinoma with lympho-vascular space invasion.

artículo científico

Synchronous primary corpus and ovarian cancer: High incidence of endometriosis and thrombosis

artículo científico publicado en 2012

Targeting dormant ovarian cancer cells in vitro and in an in vivo mouse model of platinum resistance

scientific article published on 09 October 2020

Targeting slow-proliferating ovarian cancer cells.

artículo científico publicado en 2010

The BMP signaling pathway leads to enhanced proliferation in serous ovarian cancer-A potential therapeutic target.

artículo científico publicado en 2015

The activated transforming growth factor-beta signaling pathway in peritoneal metastases is a potential therapeutic target in ovarian cancer

artículo científico publicado en 2011

The comprehensive assessment of local immune status of ovarian cancer by the clustering of multiple immune factors

artículo científico publicado en 2011

The effect of the type of dietary protein on the development of ovarian cancer.

artículo científico publicado en 2018

The mesenchymal transition subtype more responsive to dose dense taxane chemotherapy combined with carboplatin than to conventional taxane and carboplatin chemotherapy in high grade serous ovarian carcinoma: A survey of Japanese Gynecologic Oncology

artículo científico publicado en 2019

Two cases of recurrent ovarian clear cell carcinoma treated with sorafenib

scientific article published on 21 October 2013

Two cases of recurrent uterine cervical cancer with arterio-enteric fistula treated by femoro-femoral artery bypass in hybrid operation room

artículo científico publicado en 2017

Unenhanced region on magnetic resonance imaging represents tumor progression in uterine carcinosarcoma

artículo científico publicado en 2017

Utility of the 3-tier grouping system for survival discriminatory ability in stage IIA cervical cancer

scientific article published on 15 June 2020

Utilization of genomic signatures to identify high-efficacy candidate drugs for chemorefractory endometrial cancers

artículo científico publicado en 2013

VISTA expressed in tumour cells regulates T cell function

scientific article published on 09 November 2018

Venous thromboembolism, interleukin-6 and survival outcomes in patients with advanced ovarian clear cell carcinoma.

artículo científico publicado en 2015

[Clinical management of fallopian tube cancer]

artículo científico publicado en 2012

[Future Prospects of Anit-PD-1 or Anti-PD-L1 Antibody Therapy]

scientific article published on 01 February 2016

[Molecular mechanisms of peritoneal dissemination in ovarian cancer]

artículo científico publicado en 2012

[Perspectives of Individualized Treatment by Genome-Wide Analyses in Ovarian Cancer].

artículo científico publicado en 2016

Lista de obras de

A novel diagnostic criterion for lymph node metastasis in cervical cancer using multi-detector computed tomography

ASGO 2nd International Workshop on Gynecologic Oncology

Acquisition of a side population fraction augments malignant phenotype in ovarian cancer

Activated local immunity by CC chemokine ligand 19-transduced embryonic endothelial progenitor cells suppresses metastasis of murine ovarian cancer

Adenoid cystic carcinoma of skene glands: a rare origin in the female genital tract and the characteristic clinical course

Adult granulosa cell tumors of the ovary: a retrospective study of 30 cases with respect to the expression of steroid synthesis enzymes.

Advanced extragonadal yolk sac tumor serially followed up with (18)F-fluorodexyglucose-positoron emission tomography and computerized tomography and serum alpha-fetoprotein

Anti-PD-L1/PD-1 immune therapies in ovarian cancer: basic mechanism and future clinical application.

Anti-VEGF therapy resistance in ovarian cancer is caused by GM-CSF-induced myeloid-derived suppressor cell recruitment

Antitumor Effect of Nivolumab on Subsequent Chemotherapy for Platinum-Resistant Ovarian Cancer

Assessment of the early predictive power of quantitative magnetic resonance imaging parameters during neoadjuvant chemotherapy for uterine cervical cancer.

Chemotherapy Induces Programmed Cell Death-Ligand 1 Overexpression via the Nuclear Factor-κB to Foster an Immunosuppressive Tumor Microenvironment in Ovarian Cancer

Classification using hierarchical clustering of tumor-infiltrating immune cells identifies poor prognostic ovarian cancers with high levels of COX expression

Clear cell carcinoma arising from a uterus-like mass

Clinical approaches to treating papillary squamous cell carcinoma of the uterine cervix.

Clinical efficacy of neoadjuvant chemotherapy with irinotecan (CPT-11) and nedaplatin followed by radical hysterectomy for locally advanced cervical cancer

Clinical significance of the NKG2D ligands, MICA/B and ULBP2 in ovarian cancer: high expression of ULBP2 is an indicator of poor prognosis

Clinicopathological prognostic factors and the role of cytoreduction in surgical stage IVb endometrial cancer: A retrospective multi-institutional analysis of 248 patients in Japan ⬇️

Combination of Aprepitant, Azasetron, and Dexamethasone as Antiemetic Prophylaxis in Women with Gynecologic Cancers Receiving Paclitaxel/Carboplatin Therapy.

Comparison of treatment invasiveness between upfront debulking surgery versus interval debulking surgery following neoadjuvant chemotherapy for stage III/IV ovarian, tubal, and peritoneal cancers in a phase III randomised trial: Japan Clinical Oncol

Comprehensive assessment of the expression of the SWI/SNF complex defines two distinct prognostic subtypes of ovarian clear cell carcinoma.

Cyclical change of hMSH2 protein expression in normal endometrium during the menstrual cycle and its overexpression in endometrial hyperplasia and sporadic endometrial carcinoma

Distinct preoperative clinical features predict four histopathological subtypes of high-grade serous carcinoma of the ovary, fallopian tube, and peritoneum.

Distinguishing primary from secondary mucinous ovarian tumors: an algorithm using the novel marker DPEP1.

Dual Faces of IFNγ in Cancer Progression: A Role of PD-L1 Induction in the Determination of Pro- and Antitumor Immunity

Endometrial cancer implanted within a cesarean section scar

Eph-ephrin A system regulates human choriocarcinoma-derived JEG-3 cell invasion.

Epigenetic and genetic dispositions of ovarian carcinomas

Epigenetic determinants of ovarian clear cell carcinoma biology.

Epigenetic suppression of the TGF-beta pathway revealed by transcriptome profiling in ovarian cancer.

Establishment of a Novel Histopathological Classification of High-Grade Serous Ovarian Carcinoma Correlated with Prognostically Distinct Gene Expression Subtypes

Evidence-based guidelines for treatment of cervical cancer in Japan: Japan Society of Gynecologic Oncology (JSGO) 2007 edition.

Evidence-based guidelines for treatment of uterine body neoplasm in Japan: Japan Society of Gynecologic Oncology (JSGO) 2009 edition.

Exome Sequencing Landscape Analysis in Ovarian Clear Cell Carcinoma Shed Light on Key Chromosomal Regions and Mutation Gene Networks.

Expression of Vascular Endothelial Growth Factor in Ovarian Cancer Inhibits Tumor Immunity through the Accumulation of Myeloid-Derived Suppressor Cells.

Expression of p53 and p21(WAF-1), apoptosis, and proliferation of smooth muscle cells in normal myometrium during the menstrual cycle: implication of DNA damage and repair for leiomyoma development

Functional genomics identifies five distinct molecular subtypes with clinical relevance and pathways for growth control in epithelial ovarian cancer

GPR54 is a target for suppression of metastasis in endometrial cancer

Genomic profile predicts the efficacy of neoadjuvant chemotherapy for cervical cancer patients

Groin lymph node detection and sentinel lymph node biopsy in vulvar cancer

Hepatocyte nuclear factor-1β (HNF-1β) promotes glucose uptake and glycolytic activity in ovarian clear cell carcinoma

Highly conserved binding region of ACE2 as a receptor for SARS-CoV-2 between humans and mammals

Humoral hypercalcemia caused by uterine corpus carcinosarcoma consisting of squamous cell carcinoma in its epithelial component

Immune checkpoint (PD-1 and CTIA-4) signal inhibitors for gynecologic oncology; up to date

Immune checkpoint inhibition in ovarian cancer

Immunological aspect of metastasis of ovarian cancer

Impaired Wnt5a signaling in extravillous trophoblasts: Relevance to poor placentation in early gestation and subsequent preeclampsia

Invasion of uterine cervical squamous cell carcinoma cells is facilitated by locoregional interaction with cancer-associated fibroblasts via activating transforming growth factor-beta

LH/hCG action and development of ovarian cancer--a short review on biological and clinical/epidemiological aspects

Loss of Fhit protein expression in high-grade and advanced stage endometrial carcinomas.

MR imaging-based evaluation of morphological changes in the uterus and ovaries of patients following neoadjuvant chemotherapy for cervical cancer.

Magnetic resonance imaging findings and prognosis of gastric-type mucinous adenocarcinoma (minimal deviation adenocarcinoma or adenoma malignum) of the uterine corpus: Two case reports.

Menstrual cyclic change of metastin/GPR54 in endometrium

Metabolic alterations caused by HNF1β expression in ovarian clear cell carcinoma contribute to cell survival

Metabolomic Profiles of Placenta in Preeclampsia

Minimal deviation mucinous adenocarcinoma ('adenoma malignum') of the uterine corpus

Nationwide survey of severe postpartum hemorrhage in Japan: an exploratory study using the national database of health insurance claims

Oct4 Expression in Immature Teratoma of the Ovary

Outcomes of fertility-sparing surgery for stage I epithelial ovarian cancer: a proposal for patient selection

Ovarian cancer in endometriosis: molecular biology, pathology, and clinical management

Ovarian clear cell carcinoma as a stress-responsive cancer: influence of the microenvironment on the carcinogenesis and cancer phenotype.

Ovarian clear cell carcinoma meets metabolism; HNF-1β confers survival benefits through the Warburg effect and ROS reduction

PD-1/PD-L1 blockade in cancer treatment: perspectives and issues

PD-L1 on tumor cells is induced in ascites and promotes peritoneal dissemination of ovarian cancer through CTL dysfunction

Phase II trial of oral etoposide plus intravenous irinotecan in patients with platinum-resistant and taxane-pretreated ovarian cancer (JCOG0503).

Phase III trial of upfront debulking surgery versus neoadjuvant chemotherapy for stage III/IV ovarian, tubal and peritoneal cancers: Japan Clinical Oncology Group Study JCOG0602

Placental sonic hedgehog pathway regulates foetal growth via insulin-like growth factor axis in preeclampsia

Prediction of taxane and platinum sensitivity in ovarian cancer based on gene expression profiles

Primary squamous cell carcinoma of fallopian tube accompanied by gastric metaplasia of female genital tract: case report and review

Prospects and Problems of Cancer Genome Analysis for Establishing Cancer Precision Medicine

Recurrence of a carcinoid tumor of the ovary 13 years after the primary surgery: A case report

STAT1 drives tumor progression in serous papillary endometrial cancer.

Safety and Antitumor Activity of Anti-PD-1 Antibody, Nivolumab, in Patients With Platinum-Resistant Ovarian Cancer

Snail promotes ovarian cancer progression by recruiting myeloid-derived suppressor cells via CXCR2 ligand upregulation.

Solitary fibrous tumor arising slowly in the vulva over 10 years: case report and review.

Sorafenib efficacy in ovarian clear cell carcinoma revealed by transcriptome profiling.

Stress affects uterine receptivity through an ovarian-independent pathway.

Subendometrial enhancement and peritumoral enhancement for assessing endometrial cancer on dynamic contrast enhanced MR imaging

Suppression of ABHD2, identified through a functional genomics screen, causes anoikis resistance, chemoresistance and poor prognosis in ovarian cancer